Next Article in Journal
An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans
Previous Article in Journal
Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(2), 149; https://doi.org/10.3390/pharmaceutics17020149
Action Date Notes Link
article xml file uploaded 22 January 2025 12:11 CET Original file -
article xml uploaded. 22 January 2025 12:11 CET Update https://www.mdpi.com/1999-4923/17/2/149/xml
article pdf uploaded. 22 January 2025 12:11 CET Version of Record https://www.mdpi.com/1999-4923/17/2/149/pdf
article html file updated 22 January 2025 12:13 CET Original file https://www.mdpi.com/1999-4923/17/2/149/html
Back to TopTop